| Year |
Citation |
Score |
| 2008 |
Shaida N, Launchbury R, Boddy JL, Jones C, Campo L, Turley H, Kanga S, Banham AH, Malone PR, Harris AL, Fox SB. Expression of BNIP3 correlates with hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha and the androgen receptor in prostate cancer and is regulated directly by hypoxia but not androgens in cell lines. The Prostate. 68: 336-43. PMID 18163427 DOI: 10.1002/pros.20707 |
0.668 |
|
| 2007 |
Banham AH, Boddy J, Launchbury R, Han C, Turley H, Malone PR, Harris AL, Fox SB. Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia. The Prostate. 67: 1091-8. PMID 17477366 DOI: 10.1002/pros.20583 |
0.695 |
|
| 2007 |
Boddy J, Haley R, Wharton I, Sami T, Ryan P, Devarajan R. 690 A RETROSPECTIVE AUDIT OF TURP TO ASSESS THE POTENTIAL IMPACT OF GREEN LIGHT LASER SURGERY ON THE DIAGNOSIS OF PROSTATE CANCER European Urology Supplements. 6: 195. DOI: 10.1016/S1569-9056(07)60686-1 |
0.369 |
|
| 2006 |
Boddy JL, Gal S, Malone PR, Shaida N, Wainscoat JS, Harris AL. The role of cell-free DNA size distribution in the management of prostate cancer. Oncology Research. 16: 35-41. PMID 16783966 DOI: 10.3727/000000006783981297 |
0.535 |
|
| 2005 |
Boddy JL, Fox SB, Han C, Campo L, Turley H, Kanga S, Malone PR, Harris AL. The androgen receptor is significantly associated with vascular endothelial growth factor and hypoxia sensing via hypoxia-inducible factors HIF-1a, HIF-2a, and the prolyl hydroxylases in human prostate cancer Clinical Cancer Research. 11: 7658-7663. PMID 16278385 DOI: 10.1158/1078-0432.CCR-05-0460 |
0.673 |
|
| 2005 |
Boddy JL, Pike DJ, Al-Hayek S, Shaida N, Malone PR. An elevated PSA, which normalizes, does not exclude the presence of prostate cancer Prostate Cancer and Prostatic Diseases. 8: 349-352. PMID 16010283 DOI: 10.1038/sj.pcan.4500819 |
0.54 |
|
| 2005 |
Boddy JL, Gal S, Malone PR, Harris AL, Wainscoat JS. Prospective study of quantitation of plasma DNA levels in the diagnosis of malignant versus benign prostate disease. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 1394-9. PMID 15746038 DOI: 10.1158/1078-0432.CCR-04-1237 |
0.547 |
|
| 2005 |
Boddy J, Fox S, Cheng H, Hurley H, Brown P, Malone P, Banham A, Harris A. 885Co-expression of the forkhead transcription factor, FOXPI with the androgen receptor in human prostate cancer, support its role as a potential co-regulator of this receptor European Urology Supplements. 4: 224. DOI: 10.1016/S1569-9056(05)80889-9 |
0.668 |
|
| 2005 |
Boddy J, Pike D, Al-Hayek S, Malone P. 604An elevated psa which returns to within the normal range prior to biopsy does not exclude the presence of prostate cancer European Urology Supplements. 4: 153. DOI: 10.1016/S1569-9056(05)80608-6 |
0.525 |
|
| 2005 |
Boddy JL, Fox SB, Cheng H, Hurley H, Brown P, Malone PR, Harris AL. 237: Expression of the Androgen Receptor in Prostate Cancer is related to Vascular Endothelial Growth Factor and Hypoxia Inducible Factors 1: and 2 Journal of Urology. 173: 65-65. DOI: 10.1016/s0022-5347(18)34502-6 |
0.702 |
|
| 2004 |
Boddy JL, Dev S, Pike DJ, Malone PR. Intra-individual variation of serum prostate specific antigen levels in men with benign prostate biopsies Bju International. 93: 735-738. PMID 15049982 DOI: 10.1111/j.1464-410X.2003.04717.x |
0.466 |
|
| 2004 |
Boddy J, Gal S, Harris A, Wainscoat J, Malone P. 85 The diagnostic value of cell free DNA levels in prostate cancer and a reminder on the importance of sample selection European Urology Supplements. 3: 24. DOI: 10.1016/S1569-9056(04)90087-5 |
0.545 |
|
| 2003 |
Boddy JL, Pike DJ, Malone PR. A seven-year follow-up of men following a benign prostate biopsy European Urology. 44: 17-20. PMID 12814670 DOI: 10.1016/S0302-2838(03)00205-7 |
0.45 |
|
| 2003 |
Boddy J, Gal S, Malone P, Harris A, Wainscoat J. Investigating the relationship between plasma DNA levels and prostate cancer European Urology Supplements. 2: 84. DOI: 10.1016/S1569-9056(03)90445-3 |
0.549 |
|
| Show low-probability matches. |